1. Home
  2. MXE vs PMN Comparison

MXE vs PMN Comparison

Compare MXE & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mexico Equity and Income Fund Inc. (The)

MXE

Mexico Equity and Income Fund Inc. (The)

N/A

Current Price

$12.42

Market Cap

52.1M

Sector

Finance

ML Signal

N/A

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$8.76

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXE
PMN
Founded
1990
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance Companies
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.1M
23.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MXE
PMN
Price
$12.42
$8.76
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$72.67
AVG Volume (30 Days)
5.8K
43.4K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
2.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.40
$6.27
52 Week High
$11.51
$39.75

Technical Indicators

Market Signals
Indicator
MXE
PMN
Relative Strength Index (RSI) 74.64 88.71
Support Level $11.96 $7.35
Resistance Level $12.45 $9.26
Average True Range (ATR) 0.22 0.60
MACD 0.05 0.43
Stochastic Oscillator 92.87 96.99

Price Performance

Historical Comparison
MXE
PMN

About MXE Mexico Equity and Income Fund Inc. (The)

Mexico Equity and Income Fund Inc. is a closed-end, non-diversified management investment company that aims for long-term capital appreciation and current income. It prominently invests in equity, convertible securities, and debt issued by Mexican companies, operating across various sectors. The fund benchmarks its performance against the Mexbol and MSCI Mexico Index. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: